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a b s t r a c t
Ethnopharmacological relevance: The rationale for using traditional Chinese medicine (TCM) is based on
the experience that has been gained from its wide use over thousands of years. However, the mechanisms
of action of many TCM are still unclear. Proteomics, which mainly characterizes protein functions, protein–
protein interactions, and protein modiﬁcation in tissues or animals, can be used to investigate signaling
pathway perturbations in cells or the whole body. Proteomics has improved the discovery process of
effective TCM compounds, and has helped to elucidate their possible mechanisms of action. Therefore, a
systematic review of the application of proteomics on TCM research is of great importance and necessity.
This review strives to describe the literature on the application of proteomics to elucidate the mechanism
of action of TCM on various diseases, and provide the essential discussion on the further utilization of
proteomics data to accelerate TCM research.
Materials and methods: Literature survey was performed via electronic search on Pubmed with keywords
‘Proteomics’ and ‘Traditional Chinese Medicine’. The papers written in English were acquired and analyzed
in this review.
Results: This review mainly summarizes the application of proteomics to investigate TCM remedies for
neuronal disease, cancer, cardiovascular disease, diabetes, and immunology-related disease.
Conclusions: Researchers have applied proteomics to study the mechanism of action of TCM and made
substantial progresses. Further studies are required to determine the protein targets of the active
compounds, analyze the mechanism of actions in patients, compare the clinical effects with western
medicine.
& 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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1. Introduction
Traditional Chinese medicine (TCM) has been used and devel-
oped for more than several thousand years in China, but its clinical
application is limited because the pharmacology of most remedies
is unclear. Conventional medicine does not accept the rationale of
TCM because it is based on original prescription, which is incompa-
tible with modern pharmacology (Bauer and Chan, 2010). For TCM
to be modernized, it is critical to use modern technology to
determine the mechanism of action of TCM remedies. One way to
develop TCM is to separate, extract, and identify the effective
compounds. A description from a 1900 year-old book led research-
ers to identify artemisinin as the effective constituent of the malaria
treatment with the acrial part of Artemisia annua L. (青蒿). (Tu,
2011). Chen's group studied a formula that contained multiple
constituents, which was used to treat leukemia. They discovered
that the effective component of the TCM decoction was arsenic
trioxide (As2O3). Their later study determined that the mechanisms
of action of As2O3 mainly involved the induction of the apoptotic
pathway. Consequently, As2O3 is now widely used to treat acute
promyelocyte leukemia (Zhu et al., 2002; Wang et al., 2008).
Translational medicine is the conventional strategy that is used to
overcome the difﬁculty of investigating the efﬁcacy of TCM reme-
dies, which are based on the decoction of multiple herbs. PHY906
consists of 4 herbs and is derived from the formulation of Huang
Qin Tang that was initially described in Chinese canonical medicine
approximately 1800 years ago. Lam et al. (2010) using a gastro-
intestinal cancer model to study its efﬁcacy to reduce chemother-
apeutic toxicity, found that, in mice, PHY906 restored normal
intestinal structure, increased proliferating progenitor cells, blocked
inﬂammatory cell migration to the gut, and inhibited inﬂammatory
factors (Lam et al., 2010). The only 2 herbal drugs that are approved
by the Food and Drug Administration are Veregen, a polyphenon
from tea extract that is used for genital warts, and Fulyzaq, which
contains extracts from the resin of Croton lechleriMuell. Arg. (秘鲁巴
豆) that are used for diarrhea. The main obstacle preventing more
TCM remedies from meeting the stringent requirements of conven-
tional medicine is efﬁcacy and economic utilization of modern
pharmacological tools to investigate their mechanism of action.
Systems biology, which consists of genomics, epigenomics,
proteomics, and metabolomics, seeks to describe the complex
interactions between biological system components and to predict
biological system behavior (Oberg et al., 2011). Genomics is a
discipline in genetics that applies recombinant DNA, DNA sequen-
cing, and bioinformatics to sequence, assemble, and analyze the
function and structure of genomes (Freyhult et al., 2008). Epige-
netic regulation involves heritable alteration of gene expression by
modifying chromatin structure without changing primary DNA
sequences (Boonsanay et al., 2012). Metabolomics is one of the key
approaches of systems biology that consists of studying biochem-
ical networks having a set of metabolites, enzymes, reactions and
their interactions (Tagore et al., 2014). Proteomics has emerged as
a powerful tool to investigate physiological conditions, mutations,
changes in response to external factors, and adaptation. Due to rapid
developments in proteomic analytical tools such as 1-dimensional
polyacrylamide gel electrophoresis and 2-dimensional electrophor-
esis (2-DE) coupled with tandem mass spectrometry-based isobaric
tags (one of the most effective methods for analyzing the complete
proteome of cells, organs, and tissues), proteomics now allows the
systematic quantitative and qualitative mapping of the whole pro-
teome during disease (Hussain and Huygens, 2012). Proteomics can
identify altered proteins as potential drug targets, and the global
analysis of protein alterations can help understand a drug's mechan-
ism of action. Proteomics can also identify post-translational protein
modiﬁcations such as phosphorylation, glycosylation, acetylation,
and proteolysis, and sequence variants such as mutants, alternatively
spliced isoforms, and amino acid polymorphisms (Mann and Jensen,
2003; Zhang and Ge, 2011). Post-translational modiﬁcation, which
can occur after disease progression or drug treatment, substantially
affects protein function and protein-protein interactions in vitro and
in vivo. By analyzing these protein changes in tissue and cultured cells
before and after TCM treatment, proteomics is a powerful tool to
study the mechanism of action of TCM remedies (Cho, 2007).
Published papers related to the topic of the present review were
searched in Pubmed using the key words ‘proteomics’ and ‘tradi-
tional Chinese medicine’. A total of 148 papers, including 28 reviews,
were found (up to 10 February 2014). 53 papers written in Chinese
character were not involved in this review. Among 120 original
research papers, some were focused on studying syndromes of TCM
and clinical application of TCM, and some were focused on applica-
tion of Chinese medicine resources. Those papers which described
the pharmacological effects, mechanism of action, and targeted
proteins in speciﬁc diseases were selected to be discussed here.
This review summarizes the recent application of proteomics in
TCM research and development, focusing on how proteomics can
determine the mechanism of action of TCM remedies for various
diseases including neurological disease, cancer, diabetes and the
immunological response (Tables 1 and 2). Our own ﬁndings on the
application of proteomics to determine the anticancer mechan-
isms of natural compounds are also discussed. Finally, the review
Table 1
Summary of the application of proteomics to determine the mechanism of action of TCM remedies for various diseases.
Disease name TCM or compound Targets or signaling pathways References
Alzheimer's disease Hupreazine A p53 Tao et al. (2013)
Alzheimer's disease Gastrodia elata Bl. (天麻) Nxn, Dbnl, Mobkl3, Mki67 and Bax; HSP 70/90 and FKBP3/4 Manavalan et al. (2012)
Epileptic seizures Uncaria rhynchophylla (Miq.) Jacks. (钩藤) MIF and cyclophilinA Lo et al. (2010)
Cerebral artery occlusion Baicalin Energy metabolism Zhang et al. (2009)
Neurodegenerative diseases Ginkgo biloba L. (银杏) extracts PPAP subunit B and CRMP2 Koh (2011)
Cardivouscular disease Salvianolic acid B HSP27 and mitoﬁlin Feng et al. (2011)
Arrhythmias Dingxin recipe Prohibitin Jia et al. (2012)
Ischemic myocardial injury Buyang Huanwu decoction Atrial natriuretic factor, HSP β-6 and peroxiredoxin-6 Zhou et al. (2012)
Type 2 diabetes mellitus Tian-Qi-Jiang-Tang Capsule Haptoglobin, transthyretin and prothrombin Zhang et al. (2010)
Type 2 diabetes mellitus Zi-Bu-Pi-Yin recipe DRP-2 and PDHE1α, Shi et al. (2011)
Allergic airway
inﬂammation
Xiao-Qing-Long-Tang Spectrinα2 Nagai et al. (2011)
Immunological liver injury Salvia miltiorrhiza Bge. (丹参) polydacchride PRDX6 Sun et al. (2011)
Liver ﬁbrosis Fuzheng Huayu Vimentin, S-adenosylhomocysteine hydrolase isoform and HSP90 Xie et al. (2013)
Liver injury Yin-Chen-Hao-Tang Zinc ﬁnger protein 407, haptoglobin, macroglobuin, α-1-antitrypsin,
transthyretin, vitamin D-binging protein and prothrombin
Zhang et al. (2011)
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points out the challenges and perspectives for the application of
proteomics in TCM research.
2. Application of proteomics to traditional Chinese medicine
of neurological disorders
Some of the TCM remedies that are used to treat neurological
disorders such as dementia, neurodegenerative diseases, and
neuronal injury have been shown to have neuroprotection effects,
which suggests that they may be potential sources of anti-
dementia drugs (Wang et al., 2010). The whole plants of Huperzia
serrata (Thunb. Ex Murray) Trev. (蛇足石杉) has been widely used
in China for hundreds of years to relieve pain, dizziness, nausea,
and vomiting. The main active ingredient, huperzine A, is an
acetylcholinesterase inhibitor. A recent proteomics study using a
centrifugal reactor and nano-LC–MS/MS to investigate the effects
of huperzine A on neuronal cells showed that hupreazine A
protects N2a cells from amyloid β-induced cell death by decreasing
the p53 concentration (Tao et al., 2013). The TCM remedy Gastro-
dia elata Bl. (Tianma in Chinese, 天麻) is often used to treat
headaches, hypertension, and neurodegenerative diseases.
A recent proteomics study used 2-DE-LC–MS/MS-based isobaric
tagging to investigate Tianma's potential to treat neurodegenera-
tive diseases such as Alzheimer's disease. The results showed that
Tianma's mechanism of action may promote neuro-regenerative
processes by inhibiting stress-related proteins and mobilizing
neuroprotective genes such as Nucleoredoxin (Nxn), Drebrin-like
protein (Dbnl), Mps one binder kinase activator-like 3 (Mobkl3),
Ki67 protein (Mki67) and Bax with various regenerative modalities
and capacities that are related to neuro-synaptic plasticity in
mouse N2a cells (Manavalan et al., 2012). Furthermore, Tianma
modulated neuro-regenerative signaling cascades by controlling
chaperone/proteasomal degradation pathways such as heat shock
protein (HSP) 70/90 and FKBP3/4 in a human neural SH-SY5Y cell
model (Ramachandran et al., 2012). Notably, the authors used two
softwares to analyze the proteomic data. First, they used STRING
(Search Tool for the Retrieval of Interacting Genes) to analyze the
physical and functional interaction of the proteins and they revealed
the link among chaperone proteins and other metabolically
modulated proteins. Second, they used IPA (Ingenuity Pathways
Analysis) to show the complex interactive link to the identiﬁed
proteins within their networks. These data demonstrated the net-
work proteins including PKA, PKC, PLC, and RHOA etc. may also
involve in the protection effect of Tianma on neuronal cells.
The TCM remedy Uncaria rhynchophylla (Miq.) Miq. Ex Havil.
(钩藤) is also used to treat neurological disorders such as epilepsy.
MIF and cyclophilin A down-regulation has been observed in the
frontal cortex and hippocampus of rat brain tissue using 2-DE.
However, Uncaria rhynchophylla treatment overcame this effect,
which suggests that MIF and cyclophilin A partly participate in its
anticonvulsive effect (Lo et al., 2010). Furthermore, using an
ischemia/reperfusion mouse brain model, baicalin, a major poly-
phenolic compound that is derived from the dried roots of
Scutellaria baicalensis Georgi (黄芩), has been shown to be a
possible treatment for stroke. The 2-DE analysis results showed
that baicalin effectively regulated protein expression in energy
metabolism, including cellular processes, development, and bio-
logical regulation (Zhang et al., 2009). The TCM Ginkgo biloba L.
(银杏) extract is used for various health disorders such as cardi-
ovascular disease, cerebrovascular diseases, and dementia. Using a
rat cerebral ischemia model, it has been shown that EGb761, the
standard extract from the leaves, has neuroprotective effects
against neurodegenerative diseases, with evidence that it targets
various proteins such as protein phosphatase 2A (PP2A) subunit B
and Collapsing response mediator protein 2 (CRMP2) (Koh, 2011).
These studies suggested that applying proteomics within a trans-
lational medicine model could permit the determination of the
mechanisms of action of TCM remedies.
3. Application of proteomics on traditional Chinese medicine
in Cancer
More than 60% of anticancer drugs are naturally occurring,
modiﬁed natural compounds, or synthetic compounds that are
based on the structure of naturally occurring molecules (Gordaliza,
2007). Camptothecin, which is derived from Camptoteca acuminata
Decne (喜树), and its derivatives can inhibit DNA topoisomerases by
stabilizing certain intermediate complexes during DNA synthesis.
Table 2
Summary of the application of proteomics to determine the mechanism of action of compounds and plants for cancer diseases.
Type of cancer Plant Compound Cell lines Mechanism of action References
Promyelocytic
leukemia
– Arsenic trioxide and retinoic acid NB4 Calcium signaling and IFN pathway Zheng et al. (2005)
Breast cancer Curcuma longa L. Curcumin MCF-7 TDP-43,SF2/ASF, eIF3i, 3-PGDH and ERP29 Fang et al. (2011)






Ganoderic acid D HeLa 14-3-3ξ Yue et al. (2008)
Hepatocellular
carcinoma
Coptis chinensis Franch. Berberine HepG2 MAPK Tan et al. (2006)
Breast cancer Coptis chinensis Franch. Berberine MCF-7 ROS generation Chou et al. (2012)
Non small lung
cancer
Rheum palmatum L. Aloe-emodin H460 HSP70, 150 kDa oxygen-regulated protein
and protein disulﬁde isomerase
Lai et al. (2007),
Lee et al. (2005)
Colorectal
cancer
Scutellaria baicalensis Georgi Baicalein DLD-1 peroxiredoxin-6 Huang et al.
(2012)
Colon cancer Tripterygium wilfordii Hook. f. Triptolide SW480 14-3-3ξ Liu et al. (2012)
Lymphoblastoid
cells
Tripterygium wilfordii Hook. f. Celastrol Lymphoblastoid
cells













HepG2 HSP27 Fu et al. (2012b)
Cervical cancer Salvia miltiorrhiza Bge. Tanshione IIA HeLa HSP27 Pan et al. (2010)
Hepatocellular
carcinoma
Paris polyphylla Smith var.
chinensis (Franch.) Hara
Rhizomaparidis total saponin HepG2 Dnase gamma and hnRNPK Cheng et al.
(2008)
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Vinblastine and vincristine, which is derived from Vinca rosea L.
(长春花), can arrest the cell cycle by blocking the formation of
microtubules and binding to the α and β subunits of tubulin in the
S phase. Paclitaxel, which is derived from Taxus, inhibits mitosis by
acting as a microtubule-stabilizing agent.
Many bioactive natural compounds have been screened and
studied in the last few decades (Li-Weber, 2013). Arsenic trioxide
(As2O3), curcumin and berberine are under clinical trials on
various tumors and their mechanisms of action are still under
hot investigation. Chen and colleagues ﬁrst found that As2O3 was
the effective compound within a TCM decoction to treat acute
promyelocytic leukemia (APL) (Zhu et al., 2002). An integrated
cDNA microarray, proteomics, and computational biology
approach was used to determine that the administration of arsenic
trioxide and retinoic acid had the following effects: (1) activated
transcription factors and cofactors, calcium signaling, and the
proteasome system; (2) stimulated the IFN pathway; (3) degraded
the PML-RARα oncoprotein; (4) restored the nuclear body;
(5) arrested the cell cycle; and (6) caused the gain of apoptotic
potential (Zheng et al., 2005). Curcumin, which is derived from the
rhizomes of Curcuma longa L. (姜黄), and its derivatives have
gained interest due to their anti-oxidant, anti-proliferative, anti-
angiogenic, and anti-tumorigenic properties. Several studies used
proteomics to analyze the effects of curcumin on different cancer
cell lines. In the MCF-7 breast cancer cell line, proteomic analysis
identiﬁed 12 differentially expressed proteins that contributed to
multiple functional activities such as DNA transcription, mRNA
splicing and translation, amino acid synthesis, protein synthesis,
folding and degradation, lipid metabolism, glycolysis, and cell
motility (Fang et al., 2011). In neuroblastoma cell lines, curcumin
causes different responses in cisplatin-sensitive cells and resistant
cells. Shotgun analysis demonstrated that 66 proteins were differ-
entially expressed in response to curcumin treatment in sensitive
cells, and 32 proteins were signiﬁcantly modulated in the treatment-
resistant cells (D'Aguanno et al., 2012). Interestingly, the cisplatin
resistant cells exhibited impaired ubiquitin-proteasome system
(UPS) function and ROS production after curcumin treatment, which
suggests that curcumin could act as a proteasome inhibitor. Recently,
it is reported that curcumin could regulate cancer-linked inﬂamma-
tion proteins (such as COX-2 and iNOS), transcription factors (NF-κB,
STAT3, Sp, AP-1, GADD153/CHOP, HIF-1α), growth factors (VEGF,
HER2), apoptotic proteins (p53, Bcl-2, survive, DNA topoisomerase II,
DHAC2, p300, hTERT) and cell cycle proteins (cyclin D1, cyclin E,
cyclin B, p21, p27) associated with the prevention and therapy of
cancer (Hasima and Aggarwal, 2013). The ideal way to elucidate
the mechanism of action of an effective compound is to determine
the targeting proteins. Berberine is a natural product isolated from the
roots of Coptis chinensis Franch. (黄连) which has been shown to
have anti-neoplastic properties. The proteomics analysis was con-
ducted in HepG2 liver cancer cells and MCF-7 breast cancer cells.
In HepG2 cells, berberine caused G0 cell cycle arrest and apoptosis.
The mechanism included a network of proteins involved in
mitogen-activated protein kinase (MAPK) phosphorylation, meta-
bolism, cell cycle regulation and DNA damage response (Tan et al.,
2006). In MCF-7 cells, the proteomic and redox-proteomic analysis
revealed that the complex working system of berberine involved
reactive oxygen species (ROS) generation and apoptotic processes.
This study demonstrated that the protein expression and thiol
reactivity of 96 and 22 protein features, respectively, were sig-
niﬁcantly changed, and revealed that berberine-induced cytotoxi-
city in breast cancer cells involves the dysregulation of protein
folding, proteolysis, redox regulation, protein trafﬁcking, cell
signaling, electron transport, metabolism and centrosomal struc-
ture (Chou et al., 2012).
The ideal way to elucidate the mechanism of action of an
effective compound is to determine the targeting proteins. By
combining proteomics, an in silico docking program, and surface
plasmon resonance (SPR), Guo and his colleagues determined that
ganoderic acid D, a main component of Ganoderma triterpenes,
induces cytotoxicity through interacting with protein 14-3-3ξ (Yue
et al., 2008). Aloe-emodin (1,8-dihydroxy-3-(hydroxymethyl)-
anthraquinone) is one of the active constituents from the root
and rhizome of Rheum palmatum L. (大黄). In non-small lung
cancer cell line H460, the increase in the relative abundance of
certain chaperone proteins such as HSP70, 150 kDa oxygen-
regulated protein and protein disulﬁde isomerase, and the degrada-
tion of nucleophosmin were associated with aloe-emodin-induced
cell death (Lee et al., 2005; Lai et al., 2007). Natural ﬂavones such as
Apigenin, Chrysin, Wogonin, and Baicalein have anticancer activ-
ities. Their mechanisms of action are still under investigation. A
proteomics study demonstrated that Baicalein caused the up-
regulation of peroxiredoxin-6, which attenuates the generation
of ROS and inhibits the growth of colorectal cancer cells (Huang
et al., 2012).
The Tripterygium wilfordii Hook. f. (雷公藤) is a representative
TCM that has been widely and successfully used for centuries to
treat many diseases. Its anticancer activity and underlying
mechanism of action have been investigated for the last 4 decades.
The diterpenoid epoxide triptolide and the quinone triterpene
celastrol are two important bioactive ingredients that exhibit
a divergent therapeutic proﬁle and can perturb multiple signaling
pathways (Liu et al., 2011). In colon cancer, a proteomics study
revealed that triptolide treatment could induce cleavage and the
perinuclear translocation of 14-3-3ξ, which is the main protein of
cell cycle arrest and cell death (Liu et al., 2012). To investigate the
effect mechanism of celastrol in cultured human lymphoblastoid
cells, the proteomic study on celastrol was performed using SILAC
(stable isotope labeling by amino acids in cell culture), a quanti-
tative proteomics technique. Hansen found that celastrol substan-
tially modiﬁed the proteome composition, and 158 of 1800
proteins with robust quantitation showed at least a 1.5-fold
change in relative abundance. Up-regulated proteins play key roles
in cytoprotection with a prominent group involved in quality
control and the processing of proteins that traverse the endoplas-
mic reticulum. Increased levels of proteins that are essential for
cellular protection against oxidative stress including heme oxyge-
nase 1, several peroxiredoxins and thioredoxins as well as proteins
that are involved in the control of iron homeostasis were also
observed. Speciﬁc analysis of the mitochondrial proteome strongly
indicated that the mitochondrial association of certain antioxidant
defense and apoptosis-regulating proteins increased in cells that
were exposed to celastrol (Hansen et al., 2011).
Gambogic acid, a xanthonoid derived from the brownish or
orange resin of Garcinia hanburyi Hook. f. (藤黄), was found to
inhibit the growth of various cancer cells through multiple
signaling pathways such cell cycle arrest and apoptosis (Guo
et al., 2004; Zhao et al., 2004). This natural chemical was intensely
investigated in the last decade and has shown promising anti-
tumor activity in clinical trials (Chantarasriwong et al., 2010;
Anantachoke et al., 2012; Chen et al., 2012). However, the toxicity
of gambogic acid to animal's kidney and liver has limited its
application in cancer therapy (Guo et al., 2006; Qi et al., 2008).
In the last few years, we conducted a series of studies to
investigate the mechanism of action of gambogic acid and other
novel compounds that are derived from the Garcinia species (Han
and Xu, 2009). First, we investigated the stability and toxicity of
gambogic acid that was stored in different solvents (Han et al.,
2005). We then applied proteomics to demonstrate that stathmin
could be a potential target of gambogic acid in hepatocellular
carcinoma (Wang et al., 2009). Later, we used bioassay guided
fractionation to identify more than 80 compounds with anticancer
potential from Garcinia species such as Garcinia lancilimba C.Y. Wu ex
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Y.H. Li (长裂藤黄), Garcinia xishuangbannaensis Y. H. Li. (版纳藤黄),
Garcinia oblongifolia Champ. et Benth. (岭南山竹子) and Garcinia
nujiangensis C.Y. Wu ex Y.H. Li (怒江藤黄) (Han et al., 2008a; Han
et al., 2008b; Huang et al., 2009; Xia et al., 2012). We systematically
studied the possible mechanisms of action of these active com-
pounds. Our systematic proteomic analysis of these active com-
pounds showed that 1,3,6,7-tetrahydroxyxanthone, an active
compound from G. oblongifolia, suppressed cell growth by the up-
regulation of p16 and 14-3-3s in hepatocellular carcinoma cells (Fu
et al., 2012a). Our proteomics data also showed that 1,3,5-trihydroxy-
13,13-dimethyl-2H-pyran [7,6-b] xanthone, which is also derived
from G. oblongifolia, can induce cancer cell death by suppressing
HSP27 (Fu et al., 2012b). It is interesting that 2-DE analysis has shown
that tanshione IIA, a phenanthrene quinine extracted from the root of
Salvia miltiorrhiza Bge. (丹参), has also been shown to down-regulate
HSP27 expression in cervical cancer cells, indicating that HSP27 plays
an important role in the cancer cells (Pan et al., 2010). Interestingly,
we managed to use the protein docking simulation to ﬁnd out the
protein-small molecules interaction from the proteomics data, which
suggested that proteomics was an essential tool to predict the protein
targets of the active compounds.
Proteomics also made great contribution to the mechanistic
study of TCM mixtures or decoctions. Cheng et al. (2008) reported
that total saponin of the rhizomes of Paris polyphylla Smith var.
chinensis (Franch.) Hara (重楼) induced apoptosis in HepG2 cells by
up-regulating dUTPase, hnRNP K, GMP synthase and down-
regulating DNase gamma, nucleoside diphosphate kinase A, and
centrin-2-as determined by proteomics.
4. Proteomics in cardiovascular disease
Salvia miltiorrhiza Bge. and Panax notoginseng (Burk.) F.H. Chen
(三七) are well known Chinese herbs for the treatment of cardi-
ovascular disease, but their underlying mechanisms of action are
unclear. Proteomic analysis using a rat cardiac ischemia-
reperfusion model has been used to study the mechanisms of
action of salvianolic acid and notoginsengnoside, which are
derived from Salvia miltiorrhiza and Panaxnotoginseng, respec-
tively. This study showed that salvianolic acid and notoginsengno-
side inhibit the eukaryotic translation elongation factor 2 that is
involved in cell proliferation. In addition, salvianolic acid also
inhibited the activity of protein disulﬁde isomerase and prohibitin,
indicating that the 2 compounds could have different targets for
producing their cardiovascular protective effects (Yue et al., 2012).
In a rat myocardial cell ischemia-reperfusion injury model, salvia-
nolic acid B, another compound that is derived from Salvia
miltiorrhiza, has been shown to interact with epidermal growth
factor receptor (EGFR) to activate the downstream signaling
cascade involving HSP27 and mitoﬁlin (Feng et al., 2011). Dingxin
recipe, which is composed of the seeds of Ziziphus jujuba Mill. var.
spinosa (Bunge) Hu ex H. F. Chow (酸枣仁), the roots of Sophora
ﬂavescens Alt. (苦参), the roots of Coptis chinensis Franch. (黄连),
the sclerotium of Poria cocos (Schw.) Wolf (茯苓), the roots of
Codonopsis pilosula (Franch.) Nannf. (党参), the roots of Salvia
miltiorrhiza Bunge (丹参), the roots of Paeoniae lactiﬂora Pall. (赤
芍), the fruits of Trichosanthes kirilowii Maxim. (瓜蒌), the spor-
ocarp of Ganoderma lucidum (Leyss.ex Fr.) Karst. (灵芝), and the
roots and rhizomes of Panax notoginseng (Burk.) F.H. Chen (三七), is
a TCM remedy that has been used to treat arrhythmia for several
years. To better understand its underlying mechanism of action,
2-DE gels were used to identify the differentially expressed
proteins in an arrhythmia model in rats with or without dingxin
recipe pre-treatment. The alleviation of ischemia/reperfusion-
induced arrhythmias by the dingxin recipe was shown to be related
to the prohibitin increase, glutathione depletion, and interleukin-6
and neutrophil inﬁltration (Jia et al., 2012). Buyang Huanwu decoc-
tion (BYHWD), which is composed of the roots of Astragalus
membranaceus (Fisch.) Bge. (黄芪), the roots of Angelica sinensis
(Oliv.) Diels (当归), the roots of Paeoniae lactiﬂora Pall. (赤芍), the
roots of Ligusticum chuanxiong Hort. (川芎), the seeds of Prunus
persica (L.) Batsch (桃仁), the ﬂowers of Carthamus tinctorius L. (红
花), and the bodies of Pheretima aspergillum (E. Perrier) (地龙), has
been used to improve the neurological functional recovery of
stroke-induced disabilities or inhibit ischemic myocardial injury in
China. A proteomics-based approach was used to identify the
response of differentially expressed proteins to BYHWD treatment
in the ischemia-induced ventricular remodeling of rats. This study
showed that atrial natriuretic factor was down-regulated; heat
shock protein beta-6 and peroxiredoxin-6 were up-regulated in
the BYHWD-treated group, and they were among the successfully
identiﬁed proteins. The results suggested that BYHWD could
alleviate ventricular remodeling that is induced by left anterior
descending artery ligation (Zhou et al., 2012).
5. Proteomics in type 2 diabetes mellitus
Type 2 diabetes mellitus (T2DM) is one of the most prevalent
chronic diseases in the world, and it is characterized by insulin
resistance coupled with the failure of pancreatic cells to compen-
sate by adequate insulin secretion. Comparison of 2-DE mapping
in T2DM rats has shown that Tian-Qi-Jiang-Tang capsule, com-
posed of the roots of Astragalus membranaceus (Fisch.) Bge. (黄芪),
the roots and rhizomes of Panax ginseng C.A. Mey. (人参), the roots
of Coptis chinensis Franch. (黄连), the fruits of Ligustrum lucidum
Ait. (女贞子), the roots of Trichosanthes kirilowii Maxim. (天花粉),
the stems of Dendrobium nobile Lindl. (石斛), the velamen of
Lycium chinense Mill. (地骨皮), the sarcocarp of Cornus ofﬁcinalis
Sieb. et Zucc. (山茱萸), the whole plants of Eclipta prostrata (L.) L.
(旱莲草), and the galls of Rhus chinensis Mill. (五倍子), which was
used as anti-T2DM prescription in China inhibits haptoglobin,
transthyretin, and prothrombin (Zhang et al., 2010). Furthermore,
in a diabetes-induced cognitive decline model, a ﬂuorescence-
based differential gel electrophoresis proteomic method identiﬁed
novel candidate proteins that are involved in diabetes develop-
ment, such as DRP-2 and PDHE1, and also deﬁned potential
intervention targets for Zi-Bu-Pi-Yin recipe in the hippocampus
(Shi et al., 2011), which is composed of the roots and rhizomes of
Panax ginseng C. A. Mey. (人参), the rhizomes of Dioscorea opposita
Thunb. (山药), the sclerotium of Poria cocos (Schw.) Wolf (茯苓),
the roots of Paeoniae lactiﬂora Pall. (白芍), the roots of Salvia
miltiorrhiza Bunge (丹参), the seeds of Lablab purpureus (Linn.)
Sweet (白扁豆), the seeds of Nelumbo nucifera Gaertn. (莲子), the
rhizomes of Acorus tatarinowii Schott. (石菖蒲), the roots of
Polygala tenuifolia Willd. (远志), the woods of Santalum album
Linn. (檀香), the peels of Citrus reticulate Blanco(橘红), and the
roots of Glycyrrhiza uralensis Fisch.(甘草).
6. Proteomics in inﬂammatory responses
Inﬂammation is complex biological response of vascular tissues
to harmful stimuli, which is inhibited by steroid or antibiotic in
Western medicine. TCM has a variety of natural formulations to
reduce inﬂammation responses for thousands of years. However,
the mechanisms of action of TCM remedies that reduce inﬂamma-
tion are unclear. Xiao-Qing-Long-Tang decoction composed of the
herbaceous stems of Ephedra sinica Stapf (麻黄), the roots of
Paeonia lactiﬂora Pall. (芍药), the roots of Asarum sieboldii Miq.
(细辛), the roots of Zingiber ofﬁcinale Rosc. (干姜), the roots of
Glycyrrhiza uralensis Fisch.(甘草), the twigs of Cinnamomum cassia
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Presl (桂枝), the fruits of Schisandra chinensis (Turcz.) Baill. (五味
子), and the tubers of Pinellia ternata (Thunb.) Breit.(半夏), which is
Chinese herb prescription, named Shoseiyuto in Japan, is used to
treat allergic rhinitis, bronchitis, bronchial asthma, and cold
symptoms. Proteomic analysis, using an ovalbumin-sensitized
allergic airway inﬂammation model showed that Xiao-Qing-
Long-Tang reversely reduced spectrin 2 expression in lung tissue
(Nagai et al., 2011). Analysis using 2-DE, in a lipopolysaccharide-
induced immunological liver injury model, showed that Salvia
miltiorrhiza polysaccharide protected against immunological liver
injury by inhibiting NF-κB activation via the up-regulation of
PRDX6 and the subsequent attenuation of lipid peroxidation, iNOS
expression, and inﬂammation (Sun et al., 2011). Some TCM
remedies were reported to have protective effects on certain
organs so that they could be used as adjunctive therapy to reduce
toxicity and side effects. Cheng et al. (2008) devoted many efforts
to elucidate the mechanisms of PHY906, a four herbs decoction for
cancer therapy (Wang et al., 2011; Liu and Cheng, 2012). Fuzheng
Huayu (FZHY), which contains six traditional Chinese drugs, the
roots of Salvia miltiorrhiza Bunge (丹参), the fungus of Cordyceps
sinensis (Berk.) Sacc. (冬虫夏草), the seeds of Prunus persica (L.)
Batsch (桃仁), the whohe plants of Gynostemma pentaphyllum
(Thunb.) Makino (绞股蓝), the pollen of Pinus massoniana Lamb.
(松花粉), and the fruits of Schisandra chinensis (Turcz.) Baill. (五味
子), is an effective Chinese herbal product that is used to treat liver
ﬁbrosis. The complicated liver protective mechanism of FZHY was
revealed by a proteomics study that was conducted by Xie et al.
(2013). Using a dimethylnitrosamine-induced liver injury rat
model, they determined that 12 proteins were responsible for
ﬁbrogenesis induced by dimethylnitrosamine in rats, and among
them, 8 proteins in ﬁbrotic liver were regulated by FZHY, including
aldehyde dehydrogenase, vimentin isoform CRA_b, gamma-actin,
vimentin, fructose-bisphosphate aldolase B, aldo-keto reductase,
S-adenosylhomocysteine hydrolase isoform, and HSP90. These
results indicate that the mechanism of action of FZHY anti-liver
ﬁbrosis could be associated with the modulation of proteins that
are associated with metabolism and the stress response, as well as
myoﬁbroblast activation (Xie et al., 2013). Yin-Chen-Hao-Tang
(YCHT, Inchin-ko-to or TJ-135 in Japan), consisting of the acrial
part of Artemisia annua L. (青蒿), the fruits of Gardenia jasminoides
Ellis (栀子), and the roots and rhizomes of Rheum Palmatum L.
(大黄), is a widely used TCM in clinical practice for jaundice and
the treatment of liver disorders (Zhang et al., 2011). Wang and his
team performed proteomics to identify the possible target proteins
of YCHT in a CCl4-induced liver injury mouse model. As a result, 15
modulated proteins were identiﬁed in the CCl4-treatment group,
out of which 7 were found to be signiﬁcantly altered by YCHT.
YCHT treatment caused a statistically signiﬁcant down-regulation
of zinc ﬁnger protein 407, haptoglobin, macroglobulin, and alpha-
1-antitrypsin; the signiﬁcant up-regulation of transthyretin, vita-
min D-binding protein, and prothrombin, appear to be involved in
metabolism, energy generation, chaperone, antioxidation, signal
transduction, protein folding and apoptosis (Sun et al., 2013).
The proteomics studies on inﬂammatory diseases are complex
and difﬁcult to analyze. In the FZHY study, the researchers induced
liver ﬁbrosis models using intraperitoneal injection of dimethylni-
trosamine, followed with FZHY treatment. To obtain the proteo-
mics data, the liver from 3 animals were selected from each group
and homogenized for 2-D electrophoresis and image analysis. To
better understand the mechanism of FZHY recipe, the data analysis
was performed by comparing the normal group and model group,
model group and FZHY group. The complexity caused some
contradictory results in the proteomics data. For instance, vimen-
tin isoform CRA_b protein showed both down and up-regulation
between FZHY and model group. It might due to the different
cleavage or modiﬁcation of this protein in three different groups.
To better understand the function of this protein, the authors
analyzed the changes among three groups and found out that
vimentin isoform CRA_b was down-regulated by dimethylnitrosa-
mine and rescued by FZHY. However, the authors did not provide
the evidence by using other analytical method such as western
blotting or RT-PCR. It will be interesting to further study this
protein to understand the detailed mechanisms of FZHY on liver
ﬁbrosis animals.
7. Conclusion and perspectives
It is expected that applying modern technology to TCM
research and development will accelerate the integration of TCM
into Western medicine. Proteomics can identify therapeutic tar-
gets and determine the mechanisms of action of TCM remedies.
It can also be used to study the effect of a single compound, active
fractions and herbal prescriptions. Other omic technologies such
as genomics, metabolomics and metabonomics also play impor-
tant roles on TCM research (Buriani et al., 2012). Genomics,
including DNA microarray, cDNA microarrays, microRNomics ana-
lyze the changes of genes and miRNAs expression pattern under
TCM treatment. Combined with bioinformatics and statistical
analysis, it can provide the possible molecular mechanisms, down-
stream effects, and targeted pathways. However, the changes in
DNA, mRNA and miRNA expression may poorly correlate with the
changes in protein expression. Moreover, the post-translational
modiﬁcation (PTM) of proteins, such as acetylation, ubiquitination,
phosphorylation, and methylation, cannot be detected by genomic
techniques. Metabonomics measures the metabolic proﬁling (e.g.
low molecular weight metabolite) of the systems (cells, animals or
patients) and provides the holistic picture on the effects of drugs
(Lao et al., 2009). It also can analyze the urine or plasma samples
which is easy to perform in large scale research. A recent review
summarized the usage of metabonomics to analyze the TCM
syndrome research (Zhang et al., 2013). Since the metabonomics
and proteomics analyze different molecules during drug treat-
ment, they complement each other when apply to study the
mechanism of TCM. The combination of these two omic techni-
ques is a powerful tool to elucidate the pharmacological response,
biological pathways and novel biomarkers (Wang et al., 2013).
Fig. 1 shows the general proteomics procedure to apply when
studying the mechanism of action of single compound or TCM
extracts. The whole procedures involve sample preparation, 2D gel
electrophoresis, spots extraction, MS/MS analysis, bioinformatics
analysis, and candidate's validation in vitro and in vivo. SILAC
technique provides a conventional way to avoid 2D electrophor-
esis and incorporates isotopically labeled amino acid into the
proteome of the cells. Then the whole labeled proteome can be
mixed with the one from unlabeled cells and the differences in
protein expression can be read out by comparing the abundance
between these two samples. Bioinformatics analysis is one of the
most challenge steps when apply proteomics on TCM. Since the
active compounds or TCM mix always affects multiple signaling
pathways and protein targets, the essential data mining will
increase the efﬁciency of target evaluation. Currently, there are
many software platforms for the network and pathway analysis
(e.g. STRING, KEGG); researchers are encouraged to test the
proteomics data in various databases to visualize the functional
contexts of TCM. Recently, the national institutes of health (NIH) of
the U.S. launched a program called library of integrated network-
based cellular signatures (LINCS), which creates a network-based
understanding of biological changes in gene expression and other
cellular process when cells are exposed to perturbing agents
(http://www.lincsproject.org/). It will be interesting to compare
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the pharmacological effect of TCM with the agents to predict the
mechanism of action by using this database.
Proteomics could expand the new ﬁeld of TCM research and
promote the internationalization of TCM. Advances in proteomics
and biotechnology will be combined with other technologies to
address many of the aims of TCM research. Combining proteomics
and bioinformatics (functional proteomics) to study protein sig-
naling and protein-drug interactions could help to develop mole-
cular evidence-based TCM research (Ventura, 2005). High speed
and high throughput proteomics will help process the large
number of TCM remedies and, with other related technologies,
could also allow TCM remedy effects to be studied for the whole
body and not just at the molecular and cellular level. It may also
facilitate scientiﬁc dialog between TCM and conventional Western
medicine (Dai et al., 2012). Post-translational modiﬁcations (PTMs)
are the key regulators of protein activity and involve the modiﬁca-
tions of proteins by small compounds, lipids, or even a group of
chemicals. It would be interesting to apply proteomics to detect
PTMs and other parameters such as protein–protein interactions
after TCM treatment (Altelaar et al., 2013). The rapid development
of proteomics will allow scientists to perform in depth analyses of
samples including homogenous cell populations and micro-
dissected tissue. The current increase in the size of the TCM
market provides an unprecedented incentive to apply the latest
proteomics techniques to their mechanisms of actions.
Acknowledgments
This work was supported by the National Natural Science
Foundation of China (Nos. 81130069 and 81173485), and the
Innovation Program of the Shanghai Municipal Education Com-
mission (No. 13ZZ093).
References
Altelaar, A.F., Munoz, J., Heck, A.J., 2013. Next-generation proteomics: towards an
integrative view of proteome dynamics. Nature Reviews Genetics 14, 35–48.
Anantachoke, N., Tuchinda, P., Kuhakarn, C., Pohmakotr, M., Reutrakul, V., 2012.
Prenylated caged xanthones: chemistry and biology. Pharmaceutical Biology
50, 78–91.
Bauer, R., Chan, K., 2010. Special issue: traditional Chinese Medicine. Planta
Medicine 76, 1947.
Boonsanay, V., Kim, J., Braun, T., Zhou, Y., 2012. The emerging role of epigenetic
modiﬁers linking cellular metabolism and gene activity in cardiac progenitor
cells. Trends in Cardiovascular Medicine 22, 77–81.
Buriani, A., Garcia-Bermejo, M.L., Bosisio, E., Xu, Q., Li, H., Dong, X., Simmonds, M.S.,
Carrara, M., Tejedor, N., Lucio-Cazana, J., Hylands, P.J., 2012. Omic techniques in
systems biology approaches to traditional Chinese medicine research: present
and future. Journal of Ethnopharmacology 140, 535–544.
Chantarasriwong, O., Batova, A., Chavasiri, W., Theodorakis, E.A., 2010. Chemistry
and biology of the caged Garcinia xanthones. Chemistry 16, 9944–9962.
Chen, T., Zhang, R.H., He, S.C., Xu, Q.Y., Ma, L., Wang, G.C., Qiu, N., Peng, F., Chen, J.Y.,
Qiu, J.X., Peng, A.H., Chen, L.J., 2012. Synthesis and antiangiogenic activity of
novel gambogic acid derivatives. Molecules 17, 6249–6268.
Cheng, Z.X., Liu, B.R., Qian, X.P., Ding, Y.T., Hu, W.J., Sun, J., Yu, L.X., 2008. Proteomic
analysis of anti-tumor effects by Rhizoma Paridis total saponin treatment in
HepG2 cells. Journal of Ethnopharmacology 120, 129–137.
Cho, W.C., 2007. Application of proteomics in Chinese medicine research. American
Journal of Chinese Medicine 35, 911–922.
Chou, H.C., Lu, Y.C., Cheng, C.S., Chen, Y.W., Lyu, P.C., Lin, C.W., Timms, J.F., Chan, H.L.,
2012. Proteomic and redox-proteomic analysis of berberine-induced cytotoxi-
city in breast cancer cells. Journal of Proteomics 75, 3158–3176.
D'Aguanno, S., D'Agnano, I., De Canio, M., Rossi, C., Bernardini, S., Federici, G.,
Urbani, A., 2012. Shotgun proteomics and network analysis of neuroblastoma
cell lines treated with curcumin. Molecular Biosystems 8, 1068–1077.
Dai, J., Sun, S., Cao, H., Zheng, N., Wang, W., Gou, X., Su, S., Zhang, Y., 2012.
Applications of new technologies and new methods in ZHENG differentiation.
Evidence-Based Complementary and Alternative Medicine 2012, 298014.
Fang, H.Y., Chen, S.B., Guo, D.J., Pan, S.Y., Yu, Z.L., 2011. Proteomic identiﬁcation of
differentially expressed proteins in curcumin-treated MCF-7 cells. Phytomedi-
cine 18, 697–703.
Feng, L.X., Jing, C.J., Tang, K.L., Tao, L., Cao, Z.W., Wu, W.Y., Guan, S.H., Jiang, B.H.,
Yang, M., Liu, X., Guo, D.A., 2011. Clarifying the signal network of salvianolic
acid B using proteomic assay and bioinformatic analysis. Proteomics 11,
1473–1485.
Freyhult, E., Edvardsson, S., Tamas, I., Moulton, V., Poole, A.M., 2008. Fisher: a
program for the detection of H/ACA snoRNAs using MFE secondary structure
prediction and comparative genomics—assessment and update. BMC Research
Notes 1, 49.
Fu, W.M., Zhang, J.F., Wang, H., Tan, H.S., Wang, W.M., Chen, S.C., Zhu, X., Chan, T.M.,
Tse, C.M., Leung, K.S., Lu, G., Xu, H.X., Kung, H.F., 2012a. Apoptosis induced by
1,3,6,7-tetrahydroxyxanthone in Hepatocellular carcinoma and proteomic ana-
lysis. Apoptosis 17, 842–851.
Fu, W.M., Zhang, J.F., Wang, H., Xi, Z.C., Wang, W.M., Zhuang, P., Zhu, X., Chen, S.C.,
Chang, T.M., Leung, K.S., Lu, G., Xu, H.X., Kung, H.F., 2012b. Heat shock protein
27 mediates the effect of 1,3,5-trihydroxy-13,13-dimethyl-2H-pyran [7,6-b]
xanthone on mitochondrial apoptosis in hepatocellular carcinoma. Journal of
Proteomics 75, 4833–4843.
Gordaliza, M., 2007. Natural products as leads to anticancer drugs. Clinical and
Translational Oncology 9, 767–776.
Guo, Q., Qi, Q., You, Q., Gu, H., Zhao, L., Wu, Z., 2006. Toxicological studies of
gambogic acid and its potential targets in experimental animals. Basic and
Clinical Pharmacology and Toxicology 99, 178–184.
Guo, Q.L., You, Q.D., Wu, Z.Q., Yuan, S.T., Zhao, L., 2004. General gambogic acids
inhibited growth of human hepatoma SMMC-7721 cells in vitro and in nude
mice. Acta Pharmacologica Sinica 25, 769–774.
Han, Q.B., Cheung, S., Tai, J., Qiao, C.F., Song, J.Z., Xu, H.X., 2005. Stability and
cytotoxicity of gambogic acid and its derivative, gambogoic acid. Biological and
Pharmaceutical Bulletin 28, 2335–2337.
Han, Q.B., Tian, H.L., Yang, N.Y., Qiao, C.F., Song, J.Z., Chang, D.C., Luo, K.Q., Xu, H.X.,
2008a. Polyprenylated xanthones from Garcinia lancilimba showing apoptotic
effects against HeLa-C3 cells. Chemistry & Biodiversity 5, 2710–2717.
Han, Q.B., Xu, H.X., 2009. Caged Garcinia xanthones: development since 1937.
Current Medical Chemistry 16, 3775–3796.
Fig. 1. Scheme of general approaches for the application of proteomics in the
mechanistic study of TCM. Samples (cultured cells, animals or patients) are treated
with TCM (single compounds or decoction), followed by 2D gel electrophoresis and
staining. After comparison, the differentially expressed proteins are selected for
digestion and mass spectrometry. The candidates are chosen for further mechan-
istic studies including in vitro study, in vivo study, and in silico simulation.
Alternatively, samples can be labeled with isotope in TCM treated samples (SILAC,
stable isotope labeling by amino acid in cell culture). The samples then mix with
control samples and go through MS/MS analysis without 2D gel electrophoresis.
The SILAC method is more efﬁcient and reproducible compared to 2D electrophor-
esis. Other methods such as protein chips, protein microarray are be used to
analyze the proteomics of various samples.
Y. Lao et al. / Journal of Ethnopharmacology 155 (2014) 1–8 7
Han, Q.B., Yang, N.Y., Tian, H.L., Qiao, C.F., Song, J.Z., Chang, D.C., Chen, S.L., Luo, K.Q.,
Xu, H.X., 2008b. Xanthones with growth inhibition against HeLa cells from
Garcinia xipshuanbannaensis. Phytochemistry 69, 2187–2192.
Hansen, J., Palmfeldt, J., Vang, S., Corydon, T.J., Gregersen, N., Bross, P., 2011.
Quantitative proteomics reveals cellular targets of celastrol. PLoS One 6, e26634.
Hasima, N., Aggarwal, B.B., 2013. Targeting proteasomal pathways by dietary
curcumin for cancer prevention and treatment. Current Medicinal Chemistry.
PMID 23834173.
Huang, S.X., Feng, C., Zhou, Y., Xu, G., Han, Q.B., Qiao, C.F., Chang, D.C., Luo, K.Q., Xu, H.X.,
2009. Bioassay-guided isolation of xanthones and polycyclic prenylated acylphlor-
oglucinols from Garcinia oblongifolia. Journal Natural Products 72, 130–135.
Huang, W.S., Kuo, Y.H., Chin, C.C., Wang, J.Y., Yu, H.R., Sheen, J.M., Tung, S.Y., Shen, C.H.,
Chen, T.C., Sung, M.L., Liang, H.F., Kuo, H.C., 2012. Proteomic analysis of the effects of
baicalein on colorectal cancer cells. Proteomics 12, 810–819.
Hussain, M.A., Huygens, F., 2012. Proteomic and bioinformatics tools to understand
virulence mechanisms in Staphylococcus aureus. Current Proteomics 9, 2–8.
Jia, Y.H., Zhang, Y.X., Li, L.J., Liu, Y.W., Li, C.H., Fu, X.Q., Zeng, P., Wu, W.K., Sun, X.G.,
2012. Dingxin recipe prevents ischemia/reperfusion-induced arrhythmias via
up-regulating prohibitin and suppressing inﬂammatory responses. Chinese
Journal of Integrative Medicine 18, 120–129.
Koh, P.O., 2011. Identiﬁcation of proteins differentially expressed in cerebral
cortexes of Ginkgo biloba extract (EGb761)-treated rats in a middle cerebral
artery occlusion model—a proteomics approach. American Journal of Chinese
Medicine 39, 315–324.
Lai, M.Y., Hour, M.J., Wing-Cheung Leung, H., Yang, W.H., Lee, H.Z., 2007. Chaper-
ones are the target in aloe-emodin-induced human lung nonsmall carcinoma
H460 cell apoptosis. European Journal of Pharmacology 573, 1–10.
Lam, W., Bussom, S., Guan, F., Jiang, Z., Zhang, W., Gullen, E.A., Liu, S.H., Cheng, Y.C.,
2010. The four-herb Chinese medicine PHY906 reduces chemotherapy-induced
gastrointestinal toxicity. Science Translational Medicine 2, 45–59.
Lao, Y.M., Jiang, J.G., Yan, L., 2009. Application of metabonomic analytical techni-
ques in the modernization and toxicology research of traditional Chinese
medicine. British Journal of Pharmacology 157, 1128–1141.
Lee, H.Z., Wu, C.H., Chang, S.P., 2005. Release of nucleophosmin from the nucleus:
involvement in aloe-emodin-induced human lung non small carcinoma cell
apoptosis. Internatioanl Journal of Cancer 113, 971–976.
Li-Weber, M., 2013. Targeting apoptosis pathways in cancer by Chinese medicine.
Cancer Letters 332, 304–312.
Liu, S.H., Cheng, Y.C., 2012. Old formula, new Rx: the journey of PHY906 as cancer
adjuvant therapy. Journal of Ethnopharmacology 140, 614–623.
Liu, Y., Song, F., Wu, W.K.K., He, M., Zhao, L., Sun, X., Li, H., Jiang, Y., Yang, Y., Peng, K.,
2012. Triptolide inhibits colon cancer cell proliferation and induces cleavage and
translocation of 14-3-3 epsilon. Cell Biochemistry and Function 30, 271–278.
Liu, Z., Ma, L., Zhou, G.B., 2011. The main anticancer bullets of the Chinese medicinal
herb, thunder god vine. Molecules 16, 5283–5297.
Lo, W.Y., Tsai, F.J., Liu, C.H., Tang, N.Y., Su, S.Y., Lin, S.Z., Chen, C.C., Shyu, W.C., Hsieh,
C.L., 2010. Uncaria rhynchophylla upregulates the expression of MIF and
cyclophilin A in kainic acid-induced epilepsy rats: a proteomic analysis. The
American Journal of Chinese Medicine 38, 745–759.
Manavalan, A., Ramachandran, U., Sundaramurthi, H., Mishra, M., Sze, S.K., Hu, J.M.,
Feng, Z.W., Heese, K., 2012. Gastrodia elata Blume (tianma) mobilizes neuro-
protective capacities. International Journal of Biochemistry and Molecular
Biology 3, 219–241.
Mann, M., Jensen, O.N., 2003. Proteomic analysis of post-translational modiﬁca-
tions. Nature Biotechnology 21, 255–261.
Nagai, T., Nakao, M., Shimizu, Y., Kodera, Y., Oh-Ishi, M., Maeda, T., Yamada, H., 2011.
Proteomic analysis of anti-inﬂammatory effects of a Kampo (Japanese herbal)
medicine “Shoseiryuto (Xiao-Qing-Long-Tang)“ on airway inﬂammation in
a mouse model. Evidence-Based Complementary and Alternative Medicine
2011, 604196.
Oberg, A.L., Kennedy, R.B., Li, P., Ovsyannikova, I.G., Poland, G.A., 2011. Systems
biology approaches to new vaccine development. Current Opinion in Immu-
nology 23, 436–443.
Pan, T.L., Hung, Y.C., Wang, P.W., Chen, S.T., Hsu, T.K., Sintupisut, N., Cheng, C.S., Lyu, P.C.,
2010. Functional proteomic and structural insights into molecular targets related to
the growth inhibitory effect of tanshinone IIA on HeLa cells. Proteomics 10, 914–929.
Qi, Q., You, Q., Gu, H., Zhao, L., Liu, W., Lu, N., Guo, Q., 2008. Studies on the toxicity of
gambogic acid in rats. Journal of Ethnopharmacology 117, 433–438.
Ramachandran, U., Manavalan, A., Sundaramurthi, H., Sze, S.K., Feng, Z.W., Hu, J.M.,
Heese, K., 2012. Tianma modulates proteins with various neuro-regenerative
modalities in differentiated human neuronal SH-SY5Y cells. Neurochemistry
International 60, 827–836.
Shi, X., Lu, X.G., Zhan, L.B., Qi, X., Liang, L.N., Hu, S.Y., Yan, Y., Zhao, S.Y., Sui, H.,
Zhang, F.L., 2011. The effects of the Chinese medicine ZiBu PiYin recipe on the
hippocampus in a rat model of diabetes-associated cognitive decline: a
proteomic analysis. Diabetologia 54, 1888–1899.
Sun, H., Zhang, A., Yan, G., Han, Y., Sun, W., Ye, Y., Wang, X., 2013. Proteomics study
on the hepatoprotective effects of traditional Chinese medicine formulae Yin-
Chen-Hao-Tang by a combination of two-dimensional polyacrylamide gel
electrophoresis and matrix-assisted laser desorption/ionization-time of ﬂight
mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 75,
173–179.
Sun, X.G., Fu, X.Q., Cai, H.B., Liu, Q., Li, C.H., Liu, Y.W., Li, Y.J., Liu, Z.F., Song, Y.H., Lv, Z.P.,
2011. Proteomic analysis of protective effects of polysaccharides from Salvia
miltiorrhiza against immunological liver injury in mice. Phytotherapy Research 25,
1087–1094.
Tagore, S., Chowdhury, N., De, R.K., 2014. Analyzing methods for path mining with
applications in metabolomics. Gene 534, 125–138.
Tan, Y.L., Goh, D., Ong, E.S., 2006. Investigation of differentially expressed proteins
due to the inhibitory effects of berberine in human liver cancer cell line HepG2.
Molecular Biosystems 2, 250–258.
Tao, L.M., Fang, L., Yang, Y.M., Jiang, H.L., Yang, H.Y., Zhang, H., Zhou, H., 2013.
Quantitative proteomic analysis reveals the neuroprotective effects of huper-
zine A for amyloid beta treated neuroblastoma N2a cells. Proteomics 13,
1314–1324.
Tu, Y., 2011. The discovery of artemisinin (qinghaosu) and gifts from Chinese
medicine. Nature Medicine. 17, 1217–1220.
Ventura, C., 2005. CAM and cell fate targeting: molecular and energetic insights
into cell growth and differentiation. Evidence-Based Complementary and
Alternative Medicine 2, 277–283.
Wang, E., Bussom, S., Chen, J., Quinn, C., Bedognetti, D., Lam, W., Guan, F., Jiang, Z.,
Mark, Y., Zhao, Y., Stroncek, D.F., White, J., Marincola, F.M., Cheng, Y.C., 2011.
Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the
inﬂammatory process in the tumor microenvironment. BMC Medical Genomics
4, 38.
Wang, L., Zhou, G.B., Liu, P., Song, J.H., Liang, Y., Yan, X.J., Xu, F., Wang, B.S., Mao, J.H.,
Shen, Z.X., Chen, S.J., Chen, Z., 2008. Dissection of mechanisms of Chinese
medicinal formula Realgar-Indigo naturalis as an effective treatment for
promyelocytic leukemia. Proceedings of the National Academy of Sciences of
the USA 105, 4826–4831.
Wang, X., Chen, Y., Han, Q.B., Chan, C.Y., Wang, H., Liu, Z., Cheng, C.H., Yew, D.T., Lin, M.C.,
He, M.L., Xu, H.X., Sung, J.J., Kung, H.F., 2009. Proteomic identiﬁcation of molecular
targets of gambogic acid: role of stathmin in hepatocellular carcinoma. Proteomics
9, 242–253.
Wang, X.J., Yan, G.L., Zhang, A.H., Sun, H., Piao, C.Y., Li, W.Y., Sun, C., Wu, X.H., Li, X.H.,
Chen, Y., 2013. Metabolomics and proteomics approaches to characterize and assess
proteins of bear bile powder for hepatitis C virus. Chinese Journal of Natural
Medicines 11, 653–665.
Wang, Y., Huang, L.Q., Tang, X.C., Zhang, H.Y., 2010. Retrospect and prospect of
active principles from Chinese herbs in the treatment of dementia. Acta
Pharmacologica Sinica 31, 649–664.
Xia, Z.X., Zhang, D.D., Liang, S., Lao, Y.Z., Zhang, H., Tan, H.S., Chen, S.L., Wang, X.H.,
Xu, H.X., 2012. Bioassay-guided isolation of prenylated xanthones and poly-
cyclic acylphloroglucinols from the leaves of Garcinia nujiangensis. Journal of
Natural Products 75, 1459–1464.
Xie, H., Tao, Y., Lv, J., Liu, P., Liu, C., 2013. Proteomic analysis of the effect of fuzheng
huayu recipe on ﬁbrotic liver in rats. Evidence-Based Complementary and
Alternative Medicine 2013, 972863.
Yue, Q.X., Cao, Z.W., Guan, S.H., Liu, X.H., Tao, L., Wu, W.Y., Li, Y.X., Yang, P.Y., Liu, X.,
Guo, D.A., 2008. Proteomics characterization of the cytotoxicity mechanism of
ganoderic acid D and computer-automated estimation of the possible drug
target network. Molecular and Cellular Proteomics 7, 949–961.
Yue, Q.X., Xie, F.B., Song, X.Y., Wu, W.Y., Jiang, B.H., Guan, S.H., Yang, M., Liu, X., Guo, D.A.,
2012. Proteomic studies on protective effects of salvianolic acids, notoginsengno-
sides and combination of salvianolic acids and notoginsengnosides against cardiac
ischemic-reperfusion injury. Journal of Ethnopharmacology 141, 659–667.
Zhang, A., Sun, H., Yuan, Y., Sun, W., Jiao, G., Wang, X., 2011. An in vivo analysis of
the therapeutic and synergistic properties of Chinese medicinal formula Yin-
Chen-Hao-Tang based on its active constituents. Fitoterapia 82, 1160–1168.
Zhang, A.H., Sun, H., Qiu, S., Wang, X.J., 2013. Recent highlights of metabolomics in
Chinese medicine syndrome research. Evidence-Based Complementary and
Alternative Medicine 2013, 402159.
Zhang, H., Ge, Y., 2011. Comprehensive analysis of protein modiﬁcations by top-
down mass spectrometry. Circulation-Cardiovascular Genetics 4, 711.
Zhang, S.X., Sun, H., Sun, W.J., Jiao, G.Z., Wang, X.J., 2010. Proteomic study of serum
proteins in a type 2 diabetes mellitus rat model by Chinese traditional medicine
Tianqi Jiangtang Capsule administration. Journal of Pharmaceutical and Bio-
medical Analysis 53, 1011–1014.
Zhang, Z.J., Wu, R.G., Li, P.T., Liu, F., Zhang, W.S., Zhang, P., Li, P., Wang, Y.Y., 2009.
Baicalin administration is effective in positive regulation of twenty-four
ischemia/reperfusion-related proteins identiﬁed by a proteomic study. Neuro-
chemistry International 54, 488–496.
Zhao, L., Guo, Q.L., You, Q.D., Wu, Z.Q., Gu, H.Y., 2004. Gambogic acid induces
apoptosis and regulates expressions of Bax and Bcl-2 protein in human gastric
carcinoma MGC-803 cells. Biological and Pharmaceutical Bulletin 27, 998–1003.
Zheng, P.Z., Wang, K.K., Zhang, Q.Y., Huang, Q.H., Du, Y.Z., Zhang, Q.H., Xiao, D.K.,
Shen, S.H., Imbeaud, S., Eveno, E., Zhao, C.J., Chen, Y.L., Fan, H.Y., Waxman, S.,
Auffray, C., Jin, G., Chen, S.J., Chen, Z., Zhang, J., 2005. Systems analysis of
transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell
differentiation/apoptosis of promyelocytic leukemia. Proceedings of the
National Academy of Sciences of the USA 102, 7653–7658.
Zhou, Y.C., Liu, B., Li, Y.J., Jing, L.L., Wen, G., Tang, J., Xu, X., Lv, Z.P., Sun, X.G., 2012.
Effects of buyang huanwu decoction on ventricular remodeling and differential
protein proﬁle in a rat model of myocardial infarction. Evidence-Based
Complementary and Alternative Medicine 2012, 385247.
Zhu, Q., Zhang, J.W., Zhu, H.Q., Shen, Y.L., Flexor, M., Jia, P.M., Yu, Y., Cai, X., Waxman, S.,
Lanotte, M., Chen, S.J., Chen, Z., Tong, J.H., 2002. Synergic effects of arsenic trioxide
and cAMP during acute promyelocytic leukemia cell maturation subtends a novel
signaling cross-talk. Blood 99, 1014–1022.
Y. Lao et al. / Journal of Ethnopharmacology 155 (2014) 1–88
